RCT – Page 38 – Communicable Diseases Research

Quality Assessment of the Chinese Clinical Trial Protocols Regarding Treatments for Coronavirus Disease 2019

Pharmacology

Published on 2020-08-272022-10-31
Journal: Frontiers in Pharmacology [Category] COVID-19,

Hydroxychloroquine and Coronavirus Disease 2019: A Systematic Review of a Scientific Failure

Special Issue on the COVID-19 Pandemic

Published on 2020-07-312022-10-28
Journal: Rambam Maimonides Medical Journal [Category] COVID-19,

[키워드] administration adopted case sery China Chloroquine clinical evidence clinical study cohorts coronavirus coronavirus disease Course COVID-19 death effort Europe Evidence failure HCQ Hydroxychloroquine mortality rates no significant effect non-randomized observational studies observational study pandemic Prevent Prophylactic Prophylaxis provided Randomized controlled trial RCT RCTs Result review screened therapeutic treat Treatment Trial USA
[DOI] 10.5041/RMMJ.10416 PMC 바로가기 [Article Type] Special Issue on the COVID-19 Pandemic

Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis

Medicine

Published on 2020-07-292022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] 95% CI Administered adverse event adverse events aminoquinoline anti-malarial drug Anti-malarial drugs arrhythmia Azithromycin cardiac event carried Chloroquine clinical trial Combination coronavirus COVID-19 COVID-19 infection database drug ECG Effect Efficacy eight evaluated Evidence Evidence-based medicine Good HCQ Hospitalized Hydroxychloroquine In-vitro increased risk Infection inhibit laboratory parameter Major material Meta-analysis Mortality no significant effect non-randomized trial observational studies OSF outcome outcome measure pandemic participant Participants patients Primary outcome provided QT prolongation RCT reached Registration required review risk Safety SARS-CoV-2 secondary significantly increased systematic review Treatment with COVID-19
[DOI] 10.3389/fmed.2020.00482 PMC 바로가기 [Article Type] Medicine

The effectiveness and safety of traditional Chinese medicine for the treatment of children with COVID-19

4900

Published on 2020-07-242022-10-30
Journal: Medicine [Category] COVID-19, SARS,

[키워드] affected age approval CBM children children with COVID-19 China Chinese Clinical treatment CNKI Cochrane systematic review country COVID-19 COVID-19 infection database disease severity Effectiveness Efficacy Ethics Evidence include Infrastructure Intervention lack material Meta-analysis non-randomized study Novel coronavirus novel coronavirus pneumonia Odds ratio peer-reviewed performed Pneumonia protocol Quantitative Randomized controlled trial RCT RCTs Registration required Research risk of bia shown significant effect Spread subgroup analysis systematic review the patient Traditional Chinese medicine treat Treatment VIP widespread
[DOI] 10.1097/MD.0000000000021247 PMC 바로가기 [Article Type] 4900

Economic and health impacts of infectious diseases in China A protocol for systematic review and meta analysis

4900

Published on 2020-07-242022-10-30
Journal: Medicine [Category] Coronavirus, SARS,

The efficacy and safety of Lianhua Qingwen (LHQW) for coronavirus disease 2019 (COVID-19) A protocol for systematic review and meta analysis

3800

Published on 2020-07-242022-10-30
Journal: Medicine [Category] COVID-19, SARS,

Breath Regulation and yogic Exercise An online Therapy for calm and Happiness (BREATH) for frontline hospital and long-term care home staff managing the COVID-19 pandemic: A structured summary of a study protocol for a feasibility study for a randomised controlled trial

호흡 조절 및 요가 운동 COVID-19 대유행을 관리하는 최전선 병원 및 장기 요양원 직원을 위한 평온과 행복을 위한 온라인 치료(BREATH): 무작위 대조 시험에 대한 타당성 연구를 위한 연구 프로토콜의 구조화된 요약

Letter

Published on 2020-07-142022-08-13
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 active treatment All study participant All study participants allocation concealment Analysis Anxiety ARMS blinded Blinding breath breaths Canada Care collected Complete Completeness completion consent form control arm Controlled trial COVID-19 COVID-19 pandemic COVID-19 patient data entry Depression determine dissemination element eligibility English enhancement exercise feasibility feasible foundation Group allocation Health Health promotion Healthcare staff healthcare worker Healthcare workers healthy hospital IMPROVE include Insomnia interactive module Intervention involved London Long-term care management measure medium mental health mind-body intervention mindfulness Mindfulness-based muscle relaxation music therapy number objective offered online session Open-label outcome participant phase Phase I physical Prevent Program progressive muscle relaxation promotion protocol Psychoeducation randomised randomised controlled trial randomization randomize Randomized Randomized controlled trial RCT recruited recruitment REDCap reduce Research researcher Resilience resiliency retention Sample size scheduling significantly status study hypothese study hypotheses Study protocol subsequent supervision therapy Treatment Trial USA website Weekly windows Work stress yoga
[DOI] 10.1186/s13063-020-04583-w PMC 바로가기 [Article Type] Letter

Efficacy of acupuncture and moxibustion in adjuvant treatment of patients with novel coronavirus disease 2019 (COVID-19) A protocol for systematic review and meta analysis

3800

Published on 2020-07-102022-10-30
Journal: Medicine [Category] COVID-19, SARS,

Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)—protocol of randomised controlled trial AZIQUINE-ICU

Study Protocol

Published on 2020-07-082022-10-29
Journal: Trials [Category] COVID-19, SARS,

[키워드] added addition Administered Admission allergy Azithromycin benefit clinical cohort of patient Combination Controlled trial coronavirus disease coronavirus SARS-CoV-2 COVID-19 COVID-19 infection criteria Deterioration disease dose double-blind drug early administration Efficacy febrile disease groups hospital Hydroxychloroquine hypothesise ICU ICU admission in vitro include Infection intensive care intubation limit limitation lung mechanical ventilation mechanically ventilated Mortality not differ novel Novel coronavirus outcome outcomes pathway Patient patients Placebo Pregnancy Prevent prevented progressive COVID-19 Prospective randomised randomised controlled trial RCT receive Respiratory failure SARS-CoV-2 secondary severe COVID-19 Standard of care survival susceptible Symptom Treatment Trial viral replication
[DOI] 10.1186/s13063-020-04566-x PMC 바로가기 [Article Type] Study Protocol

Acupuncture for breathlessness in COVID-19 A protocol for systematic review and meta-analysis

3800

Published on 2020-07-022022-10-30
Journal: Medicine [Category] COVID-19, SARS,